Bhaskar Anand has sold RETA and made no open-market buys since Mar 2023
SVP and Chief Accounting Officer at Reata Pharmaceuticals Inc
SEC CIK 0001890784 · Filings on SEC.gov ↗
$0Bought
$540KSold
NoneLast buy
Every filing
5 filings since Mar 2023, newest first
RETASell
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer
$69K−2.0%Sep 7
RETASell
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer
$68K−2.0%Aug 17
RETASell
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer
$239K−9.0%Jun 16
RETASell
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer
$93K−4.0%May 17
RETASell
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer
$72K−3.0%Mar 6
Filings come from SEC EDGAR. Not investment advice.